Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision Toric (PhysIOL) and POD 26% Toric (PhysIOL)
NCT ID: NCT02426385
Last Updated: 2021-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2015-04-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Visual Outcomes After Implantation of the POD FT and the POD F
NCT04943809
Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses
NCT03796624
Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)
NCT02981186
Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)
NCT02042755
Clinical Study to Investigate Outcomes of Trifocal Toric IOL POD FT in Asian Eyes
NCT03844828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study primary goal is to compare the near visual acuity in both groups. Distance and intermediate visual acuities, defocus curve, refraction and straylight will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1POD26PFT
Patients implanted with the POD 26% FineVision Toric
FineVision Toric
Posterior chamber IOL which consists in a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye
2POD26PT
Patients implanted with the POD 26% Toric
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FineVision Toric
Posterior chamber IOL which consists in a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular corneal astigmatism \>1.0 dioptres by IOL Master (regularity determined by the topography of the keratometry).
* Regular corneal astigmatism \<2.5 dioptres by IOL Master (regularity determined by the topography of the keratometry).
* Group 1: patients after cataract surgery with Fine Vision toric implanted in both eyes
* Group 2: patients after cataract surgery with Ankoris implanted in both eyes
* Availability, willingness and sufficient cognitive awareness to comply with examination procedures
Exclusion Criteria
* Difficulty for cooperation (distance from their home, general health condition)
* Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
* Any ocular comorbidity
* History of ocular trauma or prior ocular surgery including refractive procedures
* Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
* Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
* IOL spherical equivalent power lower than 10 D or greater than 30D
* Complicated surgery
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beaver-Visitec International, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TaneriPODAYFT/PODAYT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.